161 related articles for article (PubMed ID: 35651789)
21. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
PeerJ; 2019; 7():e8024. PubMed ID: 31720124
[TBL] [Abstract][Full Text] [Related]
22. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
Hou J; Yao C
Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of lncRNA-SNHG17 in Lung Adenocarcinoma: A Novel Prognostic and Diagnostic Indicator.
Li X; Yuan Y; Pal M; Jiang X
Front Oncol; 2022; 12():929655. PubMed ID: 35719962
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments.
Li W; Feng SS; Wu H; Deng J; Zhou WY; Jia MX; Shi Y; Ma L; Zeng XX; Zuberi Z; Fu D; Liu X; Chen Z
Cells; 2022 Apr; 11(7):. PubMed ID: 35406786
[TBL] [Abstract][Full Text] [Related]
25. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation.
Tang W; Lu Q; Zhu J; Zheng X; Fang N; Ji S; Lu F
Front Oncol; 2022; 12():844691. PubMed ID: 35433415
[TBL] [Abstract][Full Text] [Related]
27. hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma.
Li S; Sun X; Miao S; Lu T; Wang Y; Liu J; Jiao W
Thorac Cancer; 2018 Aug; 9(8):924-930. PubMed ID: 29932500
[TBL] [Abstract][Full Text] [Related]
28. Pan-cancer analysis identifies
Yang H; Wei X; Zhang L; Xiang L; Wang P
Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
[TBL] [Abstract][Full Text] [Related]
29. Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.
Cui Y; Cui Y; Gu R; Liu Y; Wang X; Bi L; Zhang S; Fan W; Tian F; Zhan Y; Zhang N; Xing Y; Cai L
J Oncol; 2021; 2021():2659550. PubMed ID: 34987577
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma.
Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y
Front Oncol; 2021; 11():669684. PubMed ID: 34497755
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
33. Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma.
Jiang X; Yuan Y; Tang L; Wang J; Zhang D; Cho WC; Duan L
Front Oncol; 2022; 12():831997. PubMed ID: 35127546
[TBL] [Abstract][Full Text] [Related]
34. Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma.
Li M; Yang B; Li X; Ren H; Zhang L; Li L; Li W; Wang X; Zhou H; Zhang W
Int J Gen Med; 2021; 14():6261-6275. PubMed ID: 34629892
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
Liu Z; Yang S; Zhou S; Dong S; Du J
Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
37.
Wu C; Dong B; Huang L; Liu Y; Ye G; Li S; Qi Y
Front Oncol; 2021; 11():754290. PubMed ID: 34745988
[TBL] [Abstract][Full Text] [Related]
38. Identification of a competing endogenous RNA axis "SVIL-AS1/miR-103a/ICE1" associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis.
Guo L; Ding L; Tang J
Cancer Med; 2021 Sep; 10(17):6022-6034. PubMed ID: 34264003
[TBL] [Abstract][Full Text] [Related]
39. Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and
Li X; Chen X; Yuan Y; Zhai R; Cho WC; Jiang X
Front Oncol; 2022; 12():916947. PubMed ID: 35707363
[TBL] [Abstract][Full Text] [Related]
40. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
